JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2018. Vol. 63. No. 4. P. 50-57
NUCLEAR MEDICINE
DOI: 10.12737/article_5b83bc2b3c3ef1.05312079
Scintigraphy and SPECT/CT of Sentinel Lymph Nodes for Planning of Operative Intervention in Breast Cancer
A.D. Ryzhkov1, M.E. Bilik1, A.S. Krylov1, K.V. Afanaseva1, M.O. Goncharov1, S.V. Shiryaev1, A.V. Petrovsky1,2, R.P. Litvinov1, N.D. Khakurinova2
1. N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ; 2. Sechenov University, Moscow, Russia
A.D. Ryzhkov - Dr. ScI. Med., Leading Researcher; M.E. Bilik - Radiologist; A.S. Krylov - PhD Med., Radiologist, Member of EANMMI; K.V. Afanaseva - PhD Med., Оncologist, Member of the Association of Russian Oncologists; M.O. Goncharov - Radiologist; S.V. Shiryaev - Prof., Dr. Sci. Med., Head of Lab., President of the OSMI, Member of EANMMI, Member of ACNMMI, Member of SNMMI; A.V. Petrovsky - PhD Med., Deputy Director for Research, Associate Prof.; R.P. Litvinov - PhD Med., Oncologist; N.D. Khakurinova - Post-Graduate Student
Abstract
Purpose: To increase the effectiveness and quality of surgery treatment for patients with early stages of breast cancer.
Material and methods: Since 2016, 25 patients with breast cancer were examined and went through surgery. A lymphotropic colloidal radiopharmaceutical labeled with 99mTc was used; it was administered (150 MBq) the day before the operation. 20 patients received this injection intradermally into periareolar zone, 4 patients received it peritumourally (under control of ultrasound), 1 - paratumorally. Lymphoscintigraphy was performed 3 hours after injection, the images were acquired using dual-head gamma camera Symbia E (Siemens, Germany). A static multiplanar imaging (scintigraphy) (anterior, posterior, lateral projections) was performed for the sentinel nodes (SN) mapping. 25 planar examinations were performed. In 3 cases additional SPECT/CT study was performed using a hybrid SPECT/CT Symbia T2 (Siemens, Germany). Surgical intervention was done on the next day after scintigraphy. During the surgery the hand-held gamma probe NEO 2000 (Johnson & Johnson, USA) was used to localize radioactivity. The lymph nodes with the highest count (hot lymph nodes) were removed and sent for immediate histological examination. The results of immediate histological examination were evaluated again during next studies of gross specimen and slides.
Results:: During scintigraphy studies planar and SPECT/CT, 26 SN were detected in 20 women (80 %). In 15 patients only one SN lymph node was found, in 4 patients - 2, and in one case 3 SN were found. Intraoperative search of SN and immediate histological examination was conducted in 22 cases, 33 SN were found, while during planar scintigraphy only 26. In three cases, after histological examination (after obtaining examination results), patient surveillance was changed, these patients did not undergo through intraoperative radiometry and a decision was to conduct a one-stage mastectomy with regional lymphadenectomy. 10 out of 22 patients which underwent intraoperative radiometry and sentinel node biopsy, with immediate histological examination had metastases in the removed nodes, therefore lymphadenectomy had been performed. In the rest 12 patients after immediate histological examination of SN no evidence of tumor growth was found, thus lymphadenectomy was not performed. In case of three patients which did not undergo through intraoperative radiometry, lymphadenectomy was performed and after histological examination only two patients had tumor-involved SN, and one patient was clear. All intraoperative results were confirmed with next follow-up histological examinations. In 5 out of 25 patients (20 %) sentinel nodes were not founded. In these 5 cases during follow up period metastases were found in regional lymph nodes, and one patient had tumor emboli in lymphatic vessels, this considered being the cause of negative scintigraphy result. In 12 cases out of 25 (48 %) it was possible to minimize surgical management, and 13 (52 %) undergo lymphadenectomy.
Conclusion: 1) The integration of SPECT/CT method of sentinel nodes search allows to plan an optimal surgical management, and can positively affect the long-term follow-up result of treatment of patients with breast cancer, and improve the quality of life. 2) The sensitivity and positive prognostic value (PPV) of planar scintigraphy and intraoperative radiometry of searching for SN are 80, 100 and 73.3, 100 %, respectively. 3) Thanks to the method of lymphoscintigraphy, 12 (48f) of 25 women it was possible to minimize surgical management without lymphadenectomy.
Key words: sentinel lymph nodes, SPECT/CT, breast cancer
REFERENCES
- Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 1999;126(4):714-20; Discussion 720-2.
- McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18(13):2560-6. DOI: 10.1200/JCO.2000.18.13.2560.
- Kang T, Yi M, Hunt KK, et al. Does blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol. 2010;17 Suppl 3:280-5. DOI:10.1245/s10434-010-1235-5.
- McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg. 2000;231(5):724-31.
- Povoski SP, Olsen JO, Young DC, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006;13(11):1412-21. DOI:10.1245/s10434-006-9022-z.
- Yamamoto S, Maeda N, Yoshimura K, Oka M. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography. Breast. 2013;22(5):933-7. DOI:10.1016/j.breast.2013.05.001.
- Douek M, Klaase J, Monypenny I, et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the sentiMAG multicentre trial. Ann Surg Oncol. 2014;21(4):1237-45. DOI:10.1245/s10434-013-3379-6.
- Tu Weixia, Denizot B. Synthesis of small-sized rhenium sulfide colloidal nanoparticles. J Colloid Interface Sci. 2007;310(1):167-70. DOI:10.1016/j.jcis.2007.01.054.
- Fein DA, Fowble BL, Hanlon AL, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65(1):34-9.
- McGee JM, Youmans R, Clingan F, et al. The value of axillary dissection in T1a breast cancer. Am J Surg. 1996;172(5):501-4.
- Sabaté-Llobera A, Notta PC, Benítez-Segura A, et al. Selective biopsy of the sentinel lymph node in patients with breast cancer and previous excisional biopsy: is there a change in the reliability of the technique according to time from surgery? Rev Esp Med Nucl Imagen Mol. 2015;34(1):9-12. DOI: 10.1016/j.remn.2014.09.005.
- Milgrom S, Cody H, Tan L, et al. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment. Ann Surg Oncol. 2012;19(12):3762-70. DOI: 10.1245/s10434-012-2386-3.
- Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193(5):473-8.
- Motomura K, Komoike Y, Hasegawa Y, et al. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients. J Surg Oncol. 2003;82(2):91-6; Discussion 96-7. DOI:10.1002/jso.10200.
- McMasters KM, Wong SL, Martin RC 2nd, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233(5):676-87.
- Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg. 1995;130(6):654-8; Discussion 659-60.
- Krzhivitsky PI, Kanaev SV, Novikov SN, et al. Use of SPECT-CT for visualization of sentinel lymph nodes in breast cancer patients. Problems in Oncology. 2015;61(4):624-6. Russian.
- Semiglazov VF, Krivorotko PV, Petrovsky SG, et al. Prognostic value of the volume of axillary dissection in patients with breast cancer. In: The role of cancer registers in assessing the effectiveness of anti-cancer control: Proceedings of the scientific and practical conference of Russian oncologists. St. Petersburg; 2003. p. 176-8. Russian.
- Chernov VI, Afanasyev SG, Sinilkin IG, et al. Radionuclide diagnosis for detection of sentinel lymph nodes. Siberian Journal of Oncology. 2008;28(4):5-10. Russian.
For citation: Ryzhkov AD, Bilik ME, Krylov AS, Afanaseva KV, Goncharov MO, Shiryaev SV, Petrovsky AV, Litvinov RP, Khakurinova ND. Scintigraphy and SPECT/CT of Sentinel Lymph Nodes for Planning of Operative Intervention in Breast Cancer. Medical Radiology and Radiation Safety. 2018;63(4):50-7. Russian. DOI: 10.12737/article_5b83bc2b3c3ef1.05312079